Patents by Inventor Peter Boderke

Peter Boderke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising botulinum toxin
    Patent number: 11969461
    Abstract: The present invention concerns a composition comprising (a) botulinum toxin and (b) non-crosslinked hyaluronic acid and its use of the treatment or prevention of dystonia, spasticity and/or wrinkles. Further, the present invention relates to a method for cosmetically smoothing or preventing wrinkles comprising the step of administering the present composition.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: April 30, 2024
    Assignee: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Klaus Fink, Harold Taylor, Hermann Russ, Peter Boderke
  • Long-Acting Formulations of Insulin
    Publication number: 20210308225
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: February 16, 2021
    Publication date: October 7, 2021
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Composition comprising an onion extract and liposomes
    Patent number: 10967036
    Abstract: The present invention relates to a composition comprising a first onion extract (A), and liposomes, wherein at least a portion of the onion extract is encapsulated in the liposomes. Furthermore the present invention relates to a method for preparing a composition comprising a first onion extract (A), and liposomes, wherein at least a portion of the onion extract is encapsulated in the liposomes. Further, the present invention relates to a composition comprising an onion extract (A) (Allium cepa) and liposomes, obtainable by or obtained by the method. Furthermore, the present invention relates to compositions comprising a first onion extract (A), and liposomes, wherein at least a portion of the onion extract is encapsulated in the liposomes, for use in treating and/or preventing scars.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: April 6, 2021
    Assignee: HRA Pharma
    Inventors: Peter Boderke, Martina Heberer, Petra Scheppler
  • Long-Acting Formulations of Insulin
    Publication number: 20200384087
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 13, 2020
    Publication date: December 10, 2020
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Topical compositions and methods for making and using same
    Patent number: 10729667
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: August 4, 2020
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • Long-Acting Formulations of Insulin
    Publication number: 20200215163
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: September 17, 2019
    Publication date: July 9, 2020
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20190388511
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: March 28, 2019
    Publication date: December 26, 2019
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20190046616
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 14, 2019
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Topical compositions and methods for making and using same
    Patent number: 10166206
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: January 1, 2019
    Assignee: SEBELA INTERNATIONAL BERMUDA LIMITED
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • TOPICAL COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
    Publication number: 20170172943
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Application
    Filed: September 2, 2016
    Publication date: June 22, 2017
    Applicant: SEBELA INTERNATIONAL LIMITED
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • Long-Acting Formulations of Insulin
    Publication number: 20160339084
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 23, 2016
    Publication date: November 24, 2016
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Topical compositions and methods for making and using same
    Patent number: 9452173
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: September 27, 2016
    Assignee: MERZ PHARMACEUTICALS, LLC
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • Topical compositions and methods for making and using same
    Patent number: 9446131
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: September 20, 2016
    Assignee: MERZ PHARMACEUTICALS, LLC
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • Topical compositions and methods for making and using same
    Patent number: 9433680
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: September 6, 2016
    Assignee: MERZ PHARMACEUTICALS, LLC
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Hensche, Peter Boderke
  • Long-Acting Formulations of Insulin
    Publication number: 20160228516
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 11, 2016
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-acting formulations of insulin
    Patent number: 9345750
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: May 24, 2016
    Assignee: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • TOPICAL COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
    Publication number: 20160114041
    Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
    Type: Application
    Filed: December 18, 2015
    Publication date: April 28, 2016
    Inventors: Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke
  • Long-Acting Formulations of Insulin
    Publication number: 20150164999
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: February 17, 2015
    Publication date: June 18, 2015
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • CHITOSAN BEADS AND FILLER COMPRISING SUCH BEADS
    Publication number: 20140377368
    Abstract: The present invention pertains to chitosan beads consisting of chitosan cross-linked with citrate ions. The present invention furthermore pertains to a filler comprising such chitosan-citrate beads. In one embodiment of the instant invention the filler is a dermal filler. In one further embodiment of the present invention the dermal filler is for the treatment of wrinkles and/or folds. In another embodiment of the instant invention the filler is for use in the treatment of a medical condition. The filler provided in the present invention may further comprise one or more active pharmaceutical ingredients. Further, the present invention pertains to a process for preparing the filler as claimed herein.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Inventors: Kevin Kiehm, Bernhard Hauptmeier, Peter Boderke
  • Chitosan beads and filler comprising such beads
    Patent number: 8865879
    Abstract: The present invention pertains to chitosan beads consisting of chitosan cross-linked with citrate ions. The present invention furthermore pertains to a filler comprising such chitosan-citrate beads. In one embodiment of the instant invention the filler is a dermal filler. In one further embodiment of the present invention the dermal filler is for the treatment of wrinkles and/or folds. In another embodiment of the instant invention the filler is for use in the treatment of a medical condition. The filler provided in the present invention may further comprise one or more active pharmaceutical ingredients. Further, the present invention pertains to a process for preparing the filler as claimed herein.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: October 21, 2014
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Kevin Kiehm, Bernhard Hauptmeier, Peter Boderke